Announced Wed, 22 Jul · 16:54 IST
Vivimed Labs submits newspaper ad for March 2026 results
Compliance View source PDF
VIVIMEDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.0%1-day move
₹5.15
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+0.0+1.4————————
Up moveDown movePending
AI summary
Vivimed Labs has filed copies of newspaper advertisements published on July 19, 2026 in Financial Express (English) and Hosadigantha (Kannada), containing audited financial results for the quarter and year ended March 31, 2026. The results were reviewed by the suspended Audit Committee and approved by the suspended Board of Directors on July 17, 2026. Full results are available on BSE, NSE, and the company website. This is a routine SEBI compliance filing under Regulations 30 and 47.
Likely market impact
Routine regulatory disclosure; no new financial data beyond what was already filed with stock exchanges on July 17.